Maximum quantity allowed is 999
Please select the quantity
CAS RN: 83881-52-1 | Product Number: C2316
Cetirizine Dihydrochloride

Purity: >98.0%(T)(HPLC)
Synonyms:
Product Documents:
* Please contact our distributor of SEJIN CI Co., Ltd.
if you would like to purchase TCI products. The above prices do not include freight cost, customs charge and other charges to the destination. SEJIN CI Co., Ltd. (Phone: 02-2655-2480 / email:
sales@sejinci.co.kr)
* The storage conditions are subject to change without notice.
* The storage conditions are subject to change without notice.
Product Number | C2316 |
Purity / Analysis Method | >98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__2__1H__2__5ClN__2O__3·2HCl = 461.81 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
CAS RN | 83881-52-1 |
Related CAS RN | 83881-51-0 |
Reaxys Registry Number | 9100316 |
PubChem Substance ID | 87560950 |
SDBS (AIST Spectral DB) | 52376 |
Merck Index (14) | 2022 |
MDL Number | MFCD00941428 |
Specifications
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Neutralization titration) | min. 98.0 % |
Properties (reference)
Melting Point | 225 °C |
GHS
Pictogram |
![]() |
Signal Word | Warning |
Hazard Statements | H302 : Harmful if swallowed. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
RTECS# | AG0980000 |
Transport Information:
H.S.code* | 2933.59-000 |
Application
Cetirizine dihydrochloride: A Second-Generation Histamine H1-Receptor Antagonist
Cetirizine dihydrochloride is a second-generation histamine H1-receptor antagonist with a long duration of activity and low potential for interaction with drugs metabolised by the hepatic cytochrome P450 system. The active R-enantiomer of cetirizine is levocetirizine [L0264].
References
- Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistamines
- Molecular Properties and Pharmacokinetic Behavior of Cetirizine, a Zwitterionic H1-Receptor Antagonist
- Binding characteristics of cetirizine and levocetirizine to human H1 histamine receptors: contribution of Lys191 and Thr194
- Cetirizine: a review of its use in allergic disorders (a review)
- Physicochemical, pharmacological and pharmacokinetic properties of the zwitterionic antihistamines cetirizine and levocetirizine (a review)
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.